Literature DB >> 10070096

Chemotactic, mitogenic, and angiogenic actions of UTP on vascular endothelial cells.

C M Satterwhite1, A M Farrelly, M E Bradley.   

Abstract

Endothelial cells express receptors for ATP and UTP, and both UTP and ATP elicit endothelial release of vasoactive compounds such as prostacyclin and nitric oxide; however, the distinction between purine and pyrimidine nucleotide signaling is not known. We hypothesized that UTP plays a more important role in endothelial mitogenesis and chemotaxis than does ATP and that UTP is angiogenic. In cultured endothelial cells from guinea pig cardiac vasculature (CEC), both UTP and vascular endothelial growth factor (VEGF) were significant mitogenic and chemotactic factors; in contrast, ATP demonstrated no significant chemotaxis in CEC. In chick chorioallantoic membranes (CAM), UTP and VEGF treatments produced statistically significant increases in CAM vascularity compared with controls. These findings are the first evidence of chemotactic or angiogenic effects of pyrimidines; they suggest a role for pyrimidine nucleotides that is distinct from those assumed by purine nucleotides and provide for the possibility that UTP serves as an extracellular signal for processes such as endothelial repair and angiogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10070096     DOI: 10.1152/ajpheart.1999.276.3.H1091

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

1.  Extracellular nucleotides induce vasodilatation in human arteries via prostaglandins, nitric oxide and endothelium-derived hyperpolarising factor.

Authors:  Anna-Karin Wihlborg; Malin Malmsjö; Atli Eyjolfsson; Ronny Gustafsson; Kenneth Jacobson; David Erlinge
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

Review 2.  Purinergic mechanisms in breast cancer support intravasation, extravasation and angiogenesis.

Authors:  Iain L O Buxton; Nucharee Yokdang; Robert M Matz
Journal:  Cancer Lett       Date:  2010-05-28       Impact factor: 8.679

3.  P2Y₂ receptor activation decreases blood pressure and increases renal Na⁺ excretion.

Authors:  Timo Rieg; Maria Gerasimova; José L Boyer; Paul A Insel; Volker Vallon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-05-25       Impact factor: 3.619

4.  Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice.

Authors:  Shaun W Jackson; Tomokazu Hoshi; Yan Wu; Xiaofeng Sun; Keiichi Enjyoji; Eva Cszimadia; Christian Sundberg; Simon C Robson
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

5.  Stanniocalcin-1 regulates extracellular ATP-induced calcium waves in human epithelial cancer cells by stimulating ATP release from bystander cells.

Authors:  Gregory J Block; Gabriel D DiMattia; Darwin J Prockop
Journal:  PLoS One       Date:  2010-04-20       Impact factor: 3.240

6.  The P2Y2 nucleotide receptor requires interaction with alpha v integrins to access and activate G12.

Authors:  Zhongji Liao; Cheikh I Seye; Gary A Weisman; Laurie Erb
Journal:  J Cell Sci       Date:  2007-05-01       Impact factor: 5.285

7.  Thymidine 5'-O-monophosphorothioate induces HeLa cell migration by activation of the P2Y6 receptor.

Authors:  Edyta Gendaszewska-Darmach; Marcin Szustak
Journal:  Purinergic Signal       Date:  2016-01-08       Impact factor: 3.765

Review 8.  The adventitia: essential regulator of vascular wall structure and function.

Authors:  Kurt R Stenmark; Michael E Yeager; Karim C El Kasmi; Eva Nozik-Grayck; Evgenia V Gerasimovskaya; Min Li; Suzette R Riddle; Maria G Frid
Journal:  Annu Rev Physiol       Date:  2012-12-03       Impact factor: 19.318

9.  Heightened NTPDase-1/CD39 expression and angiogenesis in radiation proctitis.

Authors:  Sunil Sheth; Wissam Bleibel; Chandrashekhar Thukral; Yousif A-Rahim; Guido Beldi; Eva Csizmadia; Simon C Robson
Journal:  Purinergic Signal       Date:  2009-04-01       Impact factor: 3.765

10.  Nucleotide receptors as targets in the pharmacological enhancement of dermal wound healing.

Authors:  Edyta Gendaszewska-Darmach; Marta Kucharska
Journal:  Purinergic Signal       Date:  2011-04-26       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.